Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Feb;58(2):320-5.
doi: 10.1007/s10620-012-2362-6. Epub 2012 Aug 24.

Stimulation of calcitonin gene-related peptide release through targeting capsaicin receptor: a potential strategy for gastric mucosal protection

Affiliations
Review

Stimulation of calcitonin gene-related peptide release through targeting capsaicin receptor: a potential strategy for gastric mucosal protection

Xiu-Ju Luo et al. Dig Dis Sci. 2013 Feb.

Abstract

Calcitonin gene-related peptide (CGRP) is a predominant neurotransmitter from capsaicin-sensitive sensory nerves, which are widely distributed in the gastrointestinal system. These sensory nerves are reported to be involved in the protection of gastric mucosa against damage by various stimuli, and CGRP is a potential mediator in this process. In addition to increase in gastric mucosal blood flow, the beneficial effects of CGRP on gastric mucosa include inhibition of gastric acid secretion, prevention of cellular apoptosis and oxidative injury. The synthesis and release of CGRP is regulated by the capsaicin receptor which is known as transient receptor potential vanilloid subfamily member 1 (TRPV1) and the agonists of TRPV1 have the potential for gastric mucosal protection. So far, multiple TRPV1 agonists, including capsaicin, capsiate, anandamide and rutaecarpine are reported to exert beneficial effects on gastric mucosal injury induced by various stimuli. Therefore, the TRPV1/CGRP pathway represents a novel target for therapeutic intervention in human gastric mucosal injury.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Dig Dis Sci. 2011 Feb;56(2):314-22 - PubMed
    1. Pharmacol Rev. 1996 Jun;48(2):253-88 - PubMed
    1. Dig Dis. 2011;29(5):454-8 - PubMed
    1. Can J Physiol Pharmacol. 2010 Oct;88(10):949-59 - PubMed
    1. J Physiol Pharmacol. 2011 Apr;62(2):207-17 - PubMed

Publication types

MeSH terms

LinkOut - more resources